Navigation Links
New Yaz, Yasmin Blood-Clotting Lawsuits Allegations Update: Resource4thePeople Reports Health Canada Reports 23 Deaths Among Contraceptive Users
Date:6/14/2013

San Diego, CA (PRWEB) June 14, 2013

http://www.resource4thepeople.com/defectivedrugs/yasmin.html

Resource4thePeople is updating consumers interested in birth control litigation today with news from Canada where national media are reporting that 23 women who used the popular oral contraceptives Yaz and Yasmin have died, mostly from blood clots.*

In a June 12, 2013 posting,* the Canadian Broadcasting Company said that "According to documents obtained from Health Canada, doctors and pharmacists say Yaz and Yasmin are suspected in the deaths of the women, who mostly died suddenly from blood clots."

Health Canada is the Canadian equivalent to the U.S. Food and Drug Administration, which, on April 10, 2012, issued a Health Warning informing consumers and physicians about possible Yaz and Yasmin blood clotting side effects.**

"This news comes shortly after a Canadian judge certified*** a class-action lawsuit filed on behalf of women who are making allegations that Yaz and Yasmin can cause life-threatening blood clots," said Resource4thePeople.

"In the meantime there has been similar litigation**** ongoing in the United States in which Bayer Pharmaceuticals is defending itself against similar allegations in a multidistrict litigation that now includes thousands of plaintiffs, according to the court docket."

Resource4thePeople said it will continue to provide U.S. and Canadian consumers with timely updates about the progress of this litigation and its American network of attorneys will continue to provide free consultations to consumers who are alleging blood-clotting problems from the use of these birth control pills.

"This has now become an international litigation involving claims that women have died or suffered life-threatening side effects from the use of these contraceptives," said Resource4thePeople.

In the Canadian Broadcasting Corporation posting it was reported that "While Bayer has already paid more than $1 billion to settle thousands of lawsuits in the U.S., the drug company tells CBC News it stands by its products."

The CBC also reported in its posting that "According to the documents obtained from Health Canada, between 2007 and February 2013, doctors and pharmacists have reported 600 adverse reactions and 23 deaths where Yaz or Yasmin were suspected. More than half of the reported deaths were women under 26, with the youngest age 14."

The Canadian class-action case was certified by Justice Crane of the Ontario Superior Court of Justice in a Yaz and Yasmin class action that contains similar allegations to those contained in American lawsuits consolidated in the multidistrict litigation before a federal judge in Illinois.

Bayer has confirmed its Feb. 28, 2013 annual report***** that many of the U.S. cases are in the process of being settled.

“As these cases are being settled we are receiving inquires from consumers about whether there may be an approaching deadline affecting their ability to join in this litigation," said Resource4thePeople.

“In response to these inquiries we are informing consumers that our national network of consumers will continue to offer free legal consultations to women who used Yaz or Yasmin and have allegedly suffered serious blood-clotting problems.”

Bayer detailed in its annual report that it has settled about 4,800 of these lawsuits for over $1 billion and that there are over 13,000 claimants still seeking damages over side effects.

"As of February 12, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 4,800 claimants in the U.S. for a total amount of about US$1 billion," according to the annual report.

Bayer also has agreed****** to pay up to $24 million to settle other lawsuits involving allegations over gall bladder side effects, according to the court files in the litigation.

These settlements are a different part of this consolidated litigation in U.S. District Court for the Southern District of Illinois in which plaintiffs claimed that they suffered gall bladder injuries because they used Yaz and Yasmin as contraceptives.**

Reuters News Service reported****** March 20, 2013 that the settlements also include Yaz and Yasmin cases in state courts in California, New Jersey and Pennsylvania.

"Under the agreement, Bayer will pay $2,000 to plaintiffs who suffered gallbladder injuries and $3,000 to individuals who had their gallbladders removed, according to the agreement," Reuters reported.

Women who have filed Yaz and Yasmin blood-clotting lawsuits have claimed that they suffered blood clots, deep vein thrombosis, strokes and pulmonary embolisms as a result of their use of the contraceptives according to allegations contained in their lawsuits.****

The April 10, 2012 Food and Drug Administration warning** about Yaz and Yasmin blood-clotting side effects mirrored these allegations:

“The U.S. Food and Drug Administration (FDA) has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.”

The FDA also said that “The revised drug labels (Beyaz, Safyral, Yasmin and Yaz) will report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products. The labels also will include a summary of the previously released results of an FDA-funded study of the blood clot risk.”

Sources:
*http://www.cbc.ca/news/canada/british-columbia/story/2013/06/11/birth-control-pills-yaz-yasmin.html
**http://www.fda.gov/Drugs/DrugSafety/ucm299305.htm
***Case # 52030110, Ontario Superior Court of Justice, St. Catherine's, Ontario, Canada
**** In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation MDL No. 2100, U.S. District Court, Southern District of Illinois
*****http://www.annualreport2012.bayer.com/en/legal-risks.aspx
******http://newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_agrees_to_settle_Yasmin,_Yaz_gallbladder_lawsuits/

Read the full story at http://www.prweb.com/releases/2013/6/prweb10829396.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Yasmin, Yaz Alleged Blood-Clotting Lawsuits Update: Resource4thePeople Reports Bayer Settles Nearly 5,000 Cases for $1 Billion and also now Settling Gall Bladder Cases
2. Researchers Turn from Drugs to Mini Organs for Diabetes Cure, According to Yasmin Malhotra
3. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
4. US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke Or Heart Attack After Using Birth Control Pills Call Yaz, Or Yasmin to Call the Johnson Law Group
5. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke As Far Back As 2005 to Call The Johnson Law Group-Nationwide
6. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke in 2008, or 2009 to Call The Johnson Law Group-Before Time Runs Out
7. The US Drug Watchdog Now Urges Young Women Who Suffered a Heart Attack or Blood Clotting After Taking Yaz or Yasmin Birth Control Pills to Contact the Johnson Law Group
8. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
9. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
10. US Drug Watchdog Now Urges Women Who Had A Out Of The Blue Heart Attack Or Stroke Who Were Also Using Yaz or Yasmin Birth Control Pills To Call The Johnson Law Group ASAP
11. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... --  Divoti USA will engrave and process all ... the latest FDA requirements, which stipulates new criteria regarding medical device ... of Medical ID jewelry such as Medical ID Bracelets, can rest ... terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
Breaking Medicine Technology: